Bishop Kate N, Verma Mohit, Kim Eun-Young, Wolinsky Steven M, Malim Michael H
Department of Infectious Diseases, King's College London School of Medicine, Guy's Hospital, London, United Kingdom.
PLoS Pathog. 2008 Dec;4(12):e1000231. doi: 10.1371/journal.ppat.1000231. Epub 2008 Dec 5.
APOBEC3G (A3G) is a host cytidine deaminase that, in the absence of Vif, restricts HIV-1 replication and reduces the amount of viral DNA that accumulates in cells. Initial studies determined that A3G induces extensive mutation of nascent HIV-1 cDNA during reverse transcription. It has been proposed that this triggers the degradation of the viral DNA, but there is now mounting evidence that this mechanism may not be correct. Here, we use a natural endogenous reverse transcriptase assay to show that, in cell-free virus particles, A3G is able to inhibit HIV-1 cDNA accumulation not only in the absence of hypermutation but also without the apparent need for any target cell factors. We find that although reverse transcription initiates in the presence of A3G, elongation of the cDNA product is impeded. These data support the model that A3G reduces HIV-1 cDNA levels by inhibiting synthesis rather than by inducing degradation.
载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(A3G)是一种宿主胞苷脱氨酶,在没有病毒感染因子(Vif)的情况下,它会限制HIV-1的复制,并减少细胞中积累的病毒DNA数量。初步研究确定,A3G在逆转录过程中会诱导新生HIV-1 cDNA发生广泛突变。有人提出,这会触发病毒DNA的降解,但现在越来越多的证据表明,这种机制可能不正确。在这里,我们使用一种天然内源性逆转录酶检测方法来表明,在无细胞病毒颗粒中,A3G不仅能够在没有超突变的情况下抑制HIV-1 cDNA的积累,而且显然不需要任何靶细胞因子。我们发现,虽然逆转录在A3G存在的情况下启动,但cDNA产物的延伸受到阻碍。这些数据支持了A3G通过抑制合成而不是诱导降解来降低HIV-1 cDNA水平的模型。